Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children

被引:11
|
作者
Gomez, Lauren A. [1 ]
Crowell, Claudia S. [2 ,3 ]
Njuguna, Irene [4 ]
Cranmer, Lisa M. [5 ,6 ]
Wamalwa, Dalton [4 ]
Chebet, Daisy [4 ]
Otieno, Vincent [4 ]
Maleche-Obimbo, Elizabeth [4 ]
Gladstone, Melissa [7 ]
John-Stewart, Grace [1 ]
Benki-Nugent, Sarah [1 ]
机构
[1] Univ Washington, Dept Global Hlth, Box 359909,325 9th Ave, Seattle, WA 98104 USA
[2] Univ Washington, Dept Pediat, Div Pediat Infect Dis, Seattle, WA 98195 USA
[3] Seattle Childrens Hosp, Seattle, WA USA
[4] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya
[5] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[6] Childrens Healthcare Atlanta, Atlanta, GA USA
[7] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England
基金
美国国家卫生研究院;
关键词
child development; nutrition; Africa; Malawi Developmental Assessment Tool; PERINATALLY ACQUIRED HIV; MOTOR DEVELOPMENT; UGANDAN CHILDREN; DISEASE SEVERITY; SOUTH-AFRICA; OUTCOMES; INFANTS; ADOLESCENTS; MORTALITY; PROGRAM;
D O I
10.1097/INF.0000000000001942
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Late human immunodeficiency virus (HIV) diagnosis after severe co-morbidity remains common in resource-limited settings. Neurodevelopmental recovery during antiretroviral therapy (ART) for late-diagnosed children is understudied. We determined 6-month neurodevelopmental trajectories in HIV-infected children initiating ART during hospitalization. Methods: HIV-infected children initiated ART after HIV diagnosis during hospitalization in Kenya. The Malawi Developmental Assessment Tool was administered after clinical stabilization within 1 month and at 6 months post-ART initiation. Baseline versus 6-month Z scores for each developmental domain were compared; cofactors for change in Z scores were evaluated using linear regression. Results: Among 74 children, median age was 1.7 years (interquartile range, 0.8-2.4) and median Z scores for gross motor, fine motor, social and language domains were -1.34, -1.04, -0.53 and -0.95, respectively. At baseline, children with higher plasma viremia had lower social Z scores (P = 0.008). Better nourished (weight-for-age Z score [WAZ] -2) children had higher Z scores in all developmental domains (all P values 0.05). After 6 months on ART (n = 58), gross and fine motor Z scores improved significantly (mean change 0.39; P = 0.007 and 0.43; P = 0.001, respectively), but social and language did not. Children with better immune and growth response to ART had higher gains in gross motor (0.05 per unit-gain CD4%; P = 0.04; 0.34 per unit-gain WAZ; P = 0.006 and 0.44 per unit-gain height-for-age Z score; P = 0.005), social (0.37 per unit-gain WAZ; P = 0.002) and language (0.25 per unit-gain height-for-age Z score; P = 0.01). Conclusions: Children had significant neurodevelopmental gains during 6 months of ART, and children with better growth and immune recovery had greater improvement. Prompt commencement of ART may improve neurodevelopment in addition to immunity and growth.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 50 条
  • [21] External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy
    Pineles, Stacy L.
    Demer, Joseph L.
    Holland, Gary N.
    Ransome, Susan S.
    Bonelli, Laura
    Velez, Federico G.
    JOURNAL OF AAPOS, 2012, 16 (06): : 529 - 533
  • [22] Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy
    Velasquez, Jorge N.
    Ledesma, Bibiana A.
    Nigro, Monica G.
    Vittar, Natalia
    Rueda, Nestor
    De Carolis, Luis
    Figueiras, Olga
    Carnevale, Silvana
    Corti, Marcelo
    LUNG INDIA, 2016, 33 (01) : 88 - 91
  • [23] ANTIRETROVIRAL THERAPY AND MEDICAL-MANAGEMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD
    CONNOR, EM
    PIZZO, PA
    BALIS, F
    HUGHES, W
    KATZ, S
    MCSHERRY, G
    OLESKE, J
    SCOTT, G
    WARA, D
    WILFERT, C
    BURR, C
    GRUBMAN, S
    ABRAMS, E
    AMMANN, AJ
    BARDEGUEZ, A
    BALSLEY, JF
    BROADBENT, PA
    BROUWERS, P
    BRYSON, YJ
    COLLABELLI, N
    CONNOR, J
    COOPER, E
    DIAZ, C
    DIPAOLO, C
    FISCHER, GW
    FOWLER, MG
    FRENKEL, LM
    GRANT, R
    GOLDSMITH, JC
    GOOSBY, E
    GORDON, E
    HALE, AR
    HERNANDEZ, V
    HUSSON, R
    KOVACS, A
    KRASINSKI, K
    LUZURIAGA, K
    MCKINNEY, R
    MCINTOSH, K
    MCPHERSON, M
    MINTZ, M
    MOFENSON, LM
    MORETTI, L
    NYMAN, N
    OXTOBY, M
    RICHARTZ, K
    SANTACROSE, S
    SPECTOR, SA
    SPERLING, R
    TUDORWILLIAMS, G
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (06) : 513 - 522
  • [24] Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
    Salvadori, Nicolas
    Ngo-Giang-Huong, Nicole
    Duclercq, Chloe
    Kanjanavanit, Suparat
    Ngampiyaskul, Chaiwat
    Techakunakorn, Pornchai
    Puangsombat, Achara
    Figoni, Julie
    Mary, Jean-Yves
    Collins, Intira J.
    Cressey, Tim R.
    Le Coeur, Sophie
    Sirirungsi, Wasna
    Lallemant, Marc
    McIntosh, Kenneth
    Jourdain, Gonzague
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 (02) : 161 - 167
  • [25] Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children
    Granados, JMS
    Amador, JTR
    De Miguel, SF
    Tomé, MIG
    Conejo, PR
    Vivas, PF
    Pollán, JC
    Contreras, JR
    Espert, AN
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (10) : 863 - 867
  • [26] Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy
    Lainka, E
    Oezbek, S
    Falck, M
    Ndagijimana, J
    Niehues, T
    PEDIATRICS, 2002, 110 (05) : e56
  • [27] Cryptococcosis in human immunodeficiency virus-infected children
    Gonzalez, CE
    Shetty, D
    Lewis, LL
    Mueller, BU
    Pizzo, PA
    Walsh, TJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (09) : 796 - 800
  • [28] Viral phenotype, antiretroviral resistance and clinical evolution in human immunodeficiency virus-infected children
    Mellado, MJ
    Cilleruelo, MJ
    Ortiz, M
    Villota, J
    Garcia, M
    PerezJurado, ML
    Barreiro, G
    MartinFontelos, P
    Bernal, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) : 1032 - 1037
  • [29] Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy
    Schuster, Iris
    Thoni, Gilles Jacques
    Ederhy, Stephane
    Walther, Guillaume
    Nottin, Stephane
    Vinet, Agnes
    Boccara, Franck
    Khireddine, Mohamed
    Girard, Pierre-Marie
    Mauboussin, Jean-Marc
    Rouanet, Isabelle
    Dauzat, Michel
    Cohen, Ariel
    Messner-Pellenc, Patrick
    Obert, Philippe
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (08): : 1213 - 1217
  • [30] Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
    Appleby, P
    Beral, V
    Newton, R
    Reeves, G
    Carpenter, L
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (22): : 1823 - 1830